1H-Pyrazole-4-boronic acid, 99.00%, 25g

1,3,5,7-Tetrabromoadamantane, 97.0%, 5g

Methyl 2-cyanobenzoate, 99.0%, 1g

2-(4-BROMOPHENYL)-3-HYDROXYPROPANENITRILE, 95.0%, 1g

(S)-2-Amino-3-((S)-2-oxopyrrolidin-3-yl)propanamide hydrochloride, 97%, 10g

TERT-BUTYL 4-(HYDROXYMETHYL)-4-(TRIFLUOROMETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 500mg

4-(2-Chlorophenyl)butan-2-one, 98%, 250mg

Diethylenetriaminepentaacetic Dianhydride>98.0%(T)5g

Tazarotenic acid, 99.57%, 50mg

Colonna capillare per GC ROTI®Cap-1, 25 m, 0.32 mm, 0.25 µm, 1 Pezzo(i)

6-NITRO-1,2,3,4-TETRAHYDROQUINOLINE, 95.0%, 5g

Methyl 6-(benzyloxy)-4-chloroquinoline-2-carboxylate, 97.0%, 100mg

(S)-2-(3-Fluorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride, 95+%, 500mg